Quent Capital, LLC Gamida Cell Ltd. Transaction History

Quent Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 14, 2024	BUY	$0.68 - $1.71 $1,521 - $3,825	2,237 New	2,237 $1,000
Q1 2023 Apr 05, 2023	BUY	$0.68 - $1.71 $486 - $1,222	715 Added 46.98%	2,237 $1,000
Q4 2022 Jan 19, 2023	BUY	$1.15 - $2.1 $1,750 - $3,196	1,522 New	1,522 $0

11.4M

235K

70.5K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Quent Capital, LLC with notifications on news.